Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Theraclone Sciences, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Theraclone Sciences, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Theraclone Sciences, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Theraclone Sciences, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| Theraclone Sciences, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 9 | 2 |
| Theraclone Sciences, Inc., Pharmaceuticals &Healthcare, Deal Details | 11 | 14 |
| Venture Financing | 11 | 1 |
| Theraclone Sciences Raises US$8 Million In Extended Series B Financing | 11 | 2 |
| Theraclone Sciences Raises US$6 Million In Venture Financing | 13 | 1 |
| Theraclone Sciences Secures Additional US$1 Million In Extended Series B Financing | 14 | 2 |
| Theraclone Sciences Secures An Additional US$1.5 Million In Series B Venture Financing | 16 | 2 |
| Partnerships | 18 | 1 |
| University of Texas MD Anderson Cancer Center and Theraclone Sciences Form Joint Venture | 18 | 1 |
| Theraclone Sciences Enters Into Joint Venture With VLST To Form V-Gene | 19 | 1 |
| Theraclone Sciences Enters Into Co-Development Agreement With Pfizer | 20 | 1 |
| Merger | 21 | 1 |
| Pharmathene Terminates Merger With Theraclone Sciences | 21 | 2 |
| Licensing Agreements | 23 | 1 |
| Theraclone Sciences Enters into Licensing Agreement with Gilead Sciences | 23 | 1 |
| Zenyaku Kogyo Enters Into License Agreement With Theraclone | 24 | 1 |
| Theraclone Sciences, Inc. - Key Competitors | 25 | 1 |
| Key Employees | 26 | 1 |
| Locations And Subsidiaries | 27 | 1 |
| Head Office | 27 | 1 |
| Appendix | 28 | 1 |
| Methodology | 28 | 1 |
| About GlobalData | 28 | 1 |
| Contact Us | 28 | 1 |
| Disclaimer | 28 | 1 |